This is an unprecedented time. It is the dedication of healthcare workers that will lead us through this crisis. Thank you for everything you do.

      Calc Function

    • Calcs that help predict probability of a diseaseDiagnosis
    • Subcategory of 'Diagnosis' designed to be very sensitiveRule Out
    • Disease is diagnosed: prognosticate to guide treatmentPrognosis
    • Numerical inputs and outputsFormula
    • Med treatment and moreTreatment
    • Suggested protocolsAlgorithm

    Disease

    Select...

    Specialty

    Select...

    Chief Complaint

    Select...

    Organ System

    Select...

    Patent Pending

    Neonatal Partial Exchange for Polycythemia

    Estimates the volume of whole blood to remove and volume of crystalloid to infuse in neonatal polycythemia.

    IMPORTANT

    This dosing tool is intended to assist with calculation, not to provide comprehensive or definitive drug information. Always double-check dosing of any drug and consult your institution's blood bank or a pharmacist as necessary.

    When to Use
    Pearls/Pitfalls
    Why Use

    Neonatal polycythemia can occur during the first week of life, when the hematocrit is >65% or hemoglobin >22 g/dL. The increased viscosity associated with polycythemia impairs tissue oxygenation and can lead to congestive heart failure, CNS, pulmonary and renal complications or necrotizing enterocolitis (NEC). Partial exchanges can be used to achieve a decrease in hematocrit (generally a goal of 55-60% to avoid complications associated with large decreases) by replacing whole blood with crystalloid. Plasma replacement is generally avoided due to an association with NEC.

    • Crystalloid replacement is used due to an association between plasma replacement and NEC.
    • Neonatal blood volume can be estimated as 85 mL per kg for full term neonates and 100 mL per kg for premature neonates. 

    Calculating the volume of whole blood for replacement by crystalloid can help achieve normalization of neonatal hematocrit and avoid complications associated with polycythemia.

    oz
    Pre-term
    Term
    %
    %

    Result:

    Please fill out required fields.

    Next Steps
    Evidence
    Content Contributors
    • Alex Ryder, MD, PhD
    • Caleb Cheng, MD
    • Christopher Tormey, MD
    Content Contributors
    • Alex Ryder, MD, PhD
    • Caleb Cheng, MD
    • Christopher Tormey, MD